9th Annual Hematology and Medical Oncology Board Review: Contemporary Practice

Friday, March 12, 2021, 9:00 AM - Monday, March 15, 2021, 12:00 PM

This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

Who Should Attend 

The target audience for this program is medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents.

Live Virtual Format

This live virtual program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit and ABIM MOC points will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the course.

Course registration includes access to an online syllabus, which includes PDFs of the slides and recorded videos of the faculty presentations.

1. Learn state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers
2. Learn state-of-the-science in diagnosis, staging, and therapeutic management of hematologic cancers
3. Understand recent treatment advances in solid tumor and hematologic oncology and their impact on modern clinical practice

Live Virtual Registration Fees

• Physicians (MDs, PhDs, and DOs): $1,500
• Residents, Fellows, Nurses, and Other Healthcare Providers: $975
• Industry Professionals*: $2,625

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Registration Discounts/Promotions

• MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact [email protected] for more information.
• MSK employee registration is complimentary. However, you must complete course registration in order to attend this course. If you are registered for this course and are unable to attend, please email [email protected]. 

Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $25 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

If it has been more than 120 days since you paid for a course, or submitted a check for payment, a W9 form will need to be completed for us to refund your registration. You will not be taxed on your refund.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material activity for a maximum of 31.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 31.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MSK Course Directors 

David H. Ilson, MD, PhD
Attending Physician, Gastrointestinal Oncology Service
Division of Solid Tumor Oncology
Department of Medicine
Member, Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

Paul A. Hamlin, MD
Medical Director, David H. Koch Center for Cancer Care
Associate Attending, Lymphoma Service 
Division of Hematologic Malignancies 
Department of Medicine
Associate Professor of Medicine, Weill Cornell Medical College

 

MSK Course Faculty

Ghassan K. Abou-Alfa, MD, MBA
Attending Physician 
Gastrointestinal Oncology Service 

Carol Aghajanian, MD
Attending Physician, Chief
Gynecologic Medical Oncology Service 

Dean F. Bajorin, MD, FACP
Attending Physician
Genitourinary Oncology Service
Frederick R. Adler Senior Faculty Chair

Renier J. Brentjens, MD, PhD
Director, Cellular Therapeutics Center
Attending Physician
Leukemia Service

Andrea Cercek, MD
Associate Attending Physician
Gastrointestinal Oncology Service

Paul B. Chapman, MD
Attending Physician
Melanoma and Immunotherapeutics service

Hiram S. Cody III, MD, FACS
Attending Surgeon
Breast Service
Professor of Surgery, Weill Cornell Medical College

Chau T. Dang, MD
Regional Care Network Medical Site Director, MSK Westchester
Attending Physician 
Breast Medicine Service

Mark A. Dickson, MD
Associate Attending Physician
Sarcoma Medical Oncology Service 

Lara A. Dunn, MD
Assistant Attending Physician
Head and Neck Oncology Service

Darren R. Feldman, MD
Chair, Quality Assurance
Assistant Attending Physician
Genitourinary Oncology Service
Assistant Professor of Medicine, Weill Cornell Medical College

Devika Gajria, MD
Assistant Attending Physician 
Breast Medicine Service

Mrinal M. Gounder, MD
Assistant Attending Physician
Sarcoma Medical Oncology Service
Early Drug Development Service

Rachel N. Grisham, MD 
Associate Attending Physician
Gynecologic Medical Oncology Service

Christian Grommes, MD
Assistant Attending Physician
Brain Tumor Service

Malin Hultcrantz, MD, PhD
Assistant Attending
Myeloma Service

W. Victoria Lai, MD
Assistant Attending Physician
Thoracic Oncology Service

Simon Mantha, MD, MPH
Attending Physician 
Hematology Service

Anthony Mato, MD
Director, CLL Program
Associate Attending Physician
Leukemia Service

Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program
Attending Physician
Leukemia Service

Beryl McCormick, MD, FACR
Chief, Attending Physician
External Beam Radiotherapy Service
Professor of Radiation Oncology, Weill Cornell Medical College

Jodi Mones, MD
Associate Attending
Hematology Service

Alison Moskowitz, MD
Clinical Director, Lymphoma Inpatient Unit
Associate Attending 
Lymphoma Service

Robert J. Motzer, MD
Attending Physician
Genitourinary Oncology Service
Jack and Dorothy Byrne Chair in Clinical Oncology

Eileen M. O’Reilly, MD
Associate Director, David M. Rubenstein Center for Pancreatic Cancer
Attending Physician, Member
Gastrointestinal Oncology Service
Winthrop Rockefeller Chair in Medical Oncology
Professor of Medicine, Weill Cornell Medical College

Rekha Parameswaran, MD
Attending Physician
Hematology Service

Gregory J. Riely, MD, PhD
Vice Chair, Clinical Research
Associate Attending Physician
Thoracic Oncology Service

Leonard B. Saltz, MD
Executive Director for Clinical Value and Sustainability
Attending Physician
Gastrointestinal Oncology Service
Professor of Medicine, Weill Cornell Medical College

Rachel Sanford, MD
Assistant Attending Physician 
Breast Medicine Service

Craig S. Sauter, MD
Clinical Director, Associate Attending
Adult Bone Marrow Transplant Service

Susan K. Seo, MD
Director, Antibiotic Management Program
Attending Physician
Infectious Disease service

Susan F. Slovin, MD, PhD
Attending Physician
Genitourinary Oncology Service
Associate Chair, Academic Administration

Zsofia K. Stadler, MD
Clinical Director, Clinical Genetics Service
Associate Attending Physician
Clinical Genetics and Gastrointestinal Oncology Services

Martin S. Tallman, MD
Chief, Leukemia Service

Anna M. Varghese, MD
Assistant Attending Physician
Gastrointestinal Oncology Service

Cy Wilkins, MD
Assistant Attending
Hematology Service

Marjorie G. Zauderer, MD
Co-Director MSK Mesothelioma Program
Associate Attending Physician
Thoracic Oncology Service

Andrew D. Zelenetz, MD, PhD
Medical Director, Quality Informatics
Attending Physician
Lymphoma Service

 

Faculty Disclosures (All Faculty)